Uncategorized

Pfizer Stock: Company Halts Obesity-Drug Development. What It Means for Eli Lilly, Novo Nordisk. – Barron’s

Posted on Author Tim Hodges Comments Off on Pfizer Stock: Company Halts Obesity-Drug Development. What It Means for Eli Lilly, Novo Nordisk. – Barron’s
  1. Pfizer Stock: Company Halts Obesity-Drug Development. What It Means for Eli Lilly, Novo Nordisk.  Barron’s
  2. Pfizer scraps daily weight loss pill after liver injury in one patient  CNBC
  3. Pfizer Provides Update on Oral GLP-1 Receptor Agonist Danuglipron  Business Wire
  4. Pfizer Abandons Obesity Pill After Liver Injury in Setback  Bloomberg.com
  5. Pfizer Halts Development of Weight-Loss Pill  WSJ